AMA Arch Intern Med. 1954;93(5):667-672. doi:10.1001/archinte.1954.00240290025003.
Text Size: A A A
Published online

CHASIS, Goldring, and Baldwin in 1949 reported on the favorable use of methyl-bis (β-chloroethyl) amine hydrochloride (nitrogen mustard) in glomerulonephritis.1 Their rationale for using this drug was based on "the assumption that human glomerulonephritis is the result of tissue alterations in the kidneys induced by an antigen-antibody complex."2 Nitrogen mustard is known to inhibit antibody production. Several confirmatory reports of the use of the agent in the nephrotic syndrome have appeared in the literature.* In a recent paper Baldwin, McLean, Chasis, and Goldring stated that the evidence favoring the use of nitrogen mustard in human glomerulonephritis is equivocal.2 Dustan, Corcoran, and Haserick first used this drug in systemic lupus erythematosus with renal involvement.5

Rohn and Bond administered nitrogen mustard to five patients who had systemic lupus erythematosus without renal damage. Three cases were benefited.6

Since Duston's preliminary report, in 1951, we have treated 20 patients with active acute and subacute


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.